Concept
Limitations in the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
- This clinical trial involved a fairly small patient sample over a small period of time in only one location (Renmin Hospital)
- Patients with already severe COVID-19 were not admitted to the study
- Patients with comorbidities or other health issues were not admitted to the study
- Confounding factors were largely not accounted for
- There wasn't a super specific definition on what "standard treatment" involved
- Limited statistical analyses performed
0
1
Updated 2020-08-13
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Methods of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Results of the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Limitations in the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study
Key Discussion and Conclusion Points from the Efficacy of Hydroxychloroquine in Patients with COVID-19 Study